GM
Genmab
GMAB·NASDAQCopenhagen DKFounded 19991,500 employees
Large CapbiotechPublicOncologyHematology
Platform: DuoBody
Market Cap
$16B
All Drugs
6
Clinical Trials
11
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (GMAB)
Loading GMAB stock data...
Drug Pipeline (6 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Ribozanubrutinib | GMA-2513 | Approved | 3 | GPRC5D | LNGBM | ||
| Cevinaritide | GMA-916 | Phase 2/3 | 1 | DLL3 | CTCL | ||
| Fixaglumide | GMA-3872 | Phase 2/3 | 2 | WEE1 | ThymomaCervical Ca | ||
| GMA-1468 | GMA-1468 | NDA/BLA | 1 | PI3Kα | T2DNMOSD | ||
| GMA-729 | GMA-729 | Phase 2 | 1 | BCL-2 | SLETTR Amyloidosis | ||
| GMA-5010 | GMA-5010 | Phase 3 | 3 | JAK2 | MigraineRCC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (11)